Khaitan, Debevoise, Platinum, JSA act on 3% acquisition by Capital International in Intas Pharma

PE Firm Capital International has bought 3% stake in Intas Pharmaceuticals from ChrysCapital , for an estimated value of ₹690 crore ($107 million).

ChrysCapital will continue to hold 3% in Intas.

Deal
Capital International buys 3% stake in Intas Pharmaceuticals

Value
₹690 crore

Sector
Pharmaceuticals

Deal Type
PE

Law Firms
Capital International - Khaitan & Co, Debevoise & Plimption; ChrysCapital - Platinum Partners; Intas Pharmaceuticals - J Sagar Associates

Partners/Heads . . .

Facebook Comment